Skip to main content

GOLDMAN SACHS GROUP INC

Position in TERN — Terns Pharmaceuticals, Inc.

CIK 886982 NEW YORK, NY

Position in TERN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
1,106,961
+4.1% QoQ
Ownership
0.958%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TERN Over Time

Shares Held

Position Value (USD)

Derivatives in TERN

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
100,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in TERN

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 100,000
2026-03-31 1,106,961
2025-12-31 1,062,984
2025-09-30 546,829
2025-06-30 326,233
2025-03-31 415,021
2024-12-31 343,050
2024-09-30 418,867
2024-06-30 698,714
2024-03-31 206,986
2023-12-31 85,591
2023-09-30 259,296
2023-06-30 57,782
2023-03-31 89,304
2022-12-31 10,830
2022-09-30 11,916
2022-06-30 16,588
2022-03-31 16,427
2021-12-31 15,208